Vireo Growth Stock Price, News & Analysis
Company Description
Vireo Growth (OTC Link: VREOD) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $547.0M.
VREOD stock has declined 12.7% over the past year. Shares last traded at $11.10.
On a trailing twelve-month basis, Vireo Growth reported revenue of $268.8M with net income of -$68.1M and diluted earnings per share of $-0.09. The company operates at a net profit margin of -25.3%.
This page provides a comprehensive overview of VREOD stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Vireo Growth (VREOD) stock last traded at $11.10. Over the past 12 months, the stock has lost 12.7%. At a market capitalization of $547.0M, VREOD is classified as a small-cap stock with approximately 49.3M shares outstanding.
VREOD Rankings
Latest News
Vireo Growth has 1 recent news article, with the latest published 2 days ago. Key topics include acquisition. View all VREOD news →
SEC Filings
Vireo Growth has filed 4 recent SEC filings, including 2 Form 4, 1 Form 8-K/A, 1 Form 8-K. The most recent filing was submitted on June 18, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all VREOD SEC filings →
Financial Highlights
Vireo Growth generated $268.8M in revenue over the trailing twelve months, retaining a 47.3% gross margin, operating income reached -$1.0M (-0.4% operating margin), and net income was -$68.1M, reflecting a -25.3% net profit margin. Diluted earnings per share stood at $-0.09. The company generated $3.7M in operating cash flow. With a current ratio of 1.59, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Days to Cover History
VREOD Company Profile & Sector Positioning
Vireo Growth (VREOD) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.